Some investors asked Tonghua Jinma on an interactive platform. Does the new drug have curative effects on diseases such as Parkinson's? Tonghua Jinma replied that the company's new drug, amviacridine succinate tablets, is used to treat mild to moderate symptoms of Alzheimer's disease. For details, please refer to the “Notice Concerning Obtaining Anviacridine Succinate Tablets ＜Drug Registration Certificate＞” issued by the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.